Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, et al.
Hepatology (2022) Vol. 77, Iss. 2, pp. 659-702
Open Access | Times Cited: 161

Showing 26-50 of 161 citing articles:

Assessing patient-reported outcomes in primary sclerosing cholangitis: an update
Donna M. Evon, Bryce B. Reeve
Current Opinion in Gastroenterology (2025)
Closed Access
Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma
C. O'Donnell, Umair Majeed, Michael Rutenberg, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 82-82
Open Access
Cholestatic liver diseases: modern therapeutics
Bridgette B. McNally, Elizabeth J. Carey
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Onset of autoimmune hepatitis in children and adolescents considering disease phenotypes
М.Б. Дыба
CHILD`S HEALTH (2025) Vol. 20, Iss. 1, pp. 20-28
Open Access
Endoscopic management of primary sclerosing cholangitis
Suguru Mizuno, Yoshihito Uchida, Satsuki Ando, et al.
Digestive Endoscopy (2025)
Open Access
Cholangiocarcinoma: The era of liquid biopsy
Evgenia Kotsifa, Francesca Saffioti, Vasileios Mavroeidis
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
Primary sclerosing cholangitis
Michael P. Manns, Annika Bergquist, Tom H. Karlsen, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access
Racial Differences in Liver Fibrosis Burden
Michael L. Attanasi, Mathew J. Gregoski, Don C. Rockey
Digestive Diseases and Sciences (2025)
Closed Access
Leveraging machine learning for precision medicine: a predictive model for cognitive impairment in cholestasis patients
Fang Cheng, Lina Zhang, Lanlan Xu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Autoimmune Disorders of the Liver and Biliary Tract
C. M. Anderson, Christopher L. Welle, Daniel Ludwig, et al.
Radiographics (2025) Vol. 45, Iss. 4
Closed Access
Machine Learning Prediction Model of Waitlist Outcomes in Patients with Primary Sclerosing Cholangitis
Elisa Pasini, Maryam Naghibzadeh, Yingji Sun, et al.
Transplantation Direct (2025) Vol. 11, Iss. 4, pp. e1774-e1774
Open Access
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives
Lucia Cerrito, Maria Elena Ainora, Raffaele Borriello, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3393-3393
Open Access | Times Cited: 11
Current Therapeutics in Primary Sclerosing Cholangitis
Natassia Tan, John Lubel, William Kemp, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 10
Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data
Chang Hu, Ravishankar K. Iyer, Brian D. Juran, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence
Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6660-6660
Open Access | Times Cited: 9
Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases
Weici Zhang, Charles R. Mackay, M. Eric Gershwin
The Journal of Immunology (2023) Vol. 210, Iss. 11, pp. 1629-1639
Closed Access | Times Cited: 9
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
You Sun Kim, Edward Hurley, Yoojeong Park, et al.
Intestinal Research (2023) Vol. 21, Iss. 4, pp. 420-432
Open Access | Times Cited: 9
Advances in the Early Detection of Hepatobiliary Cancers
Hasan Çağrı Yıldırım, Gözde Kavgacı, Elvin Chalabiyev, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3880-3880
Open Access | Times Cited: 9
Liver transplant in primary sclerosing cholangitis: Current trends and future directions
Yash R Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 8, pp. 939-953
Open Access | Times Cited: 9
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4947-4947
Open Access | Times Cited: 9
Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts
Burcin Özdirik, Bernd Schnabl
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 17, Iss. 3, pp. 423-438
Open Access | Times Cited: 9
Trends in liver transplantation for primary sclerosing cholangitis
Maria Cristina Morelli, Martina Gambato, Silvia Martini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 8, pp. 1343-1349
Closed Access | Times Cited: 3
The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)
Martin Cornillet, Christina Villard, Fredrik Rorsman, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102526-102526
Open Access | Times Cited: 3
Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study
Palak Trivedi, Katherine Arndtz, Nadir Abbas, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 11, pp. 1366-1375
Open Access | Times Cited: 3
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis
Natassia Tan, Natalie Ngu, Thomas Worland, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 3

Scroll to top